C-2-Decoumaroylaloeresin G

CAS No. 1059182-21-6

C-2-Decoumaroylaloeresin G( ——— )

Catalog No. M38597 CAS No. 1059182-21-6

C-2-Decoumaroylaloeresin G

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    C-2-Decoumaroylaloeresin G
  • Note
    Research use only, not for human use.
  • Brief Description
    C-2-Decoumaroylaloeresin G
  • Description
    C-2-Decoumaroylaloeresin G
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1059182-21-6
  • Formula Weight
    392.4
  • Molecular Formula
    C20H24O8
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lv L, et al.BACE1 (beta-secretase) inhibitory chromone glycosides from Aloe vera and Aloe nobilis. Planta Med. 2008 Apr;74(5):540-5.?
molnova catalog
related products
  • Linzagolix

    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.

  • Schisanhenol

    Schisanhenol has antioxidative effect on human LDL oxidation, may be through scavenging free radicals. Schisanhenol has anti-apoptosis effect on BACSs, may be related to its inhibition of ROS generation.

  • IL-1a (223-250) (hum...

    IL-1a (223-250) (human)